Publications found:
512,290
Sort by:
Global Urological Surgical Forceps Market Growth 2026-2032
US$ 3,660.00
The global Urological Surgical Forceps market size is predicted to grow from US$ 225 million in 2025 to US$ 313 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032. Urological...
January 2026
108 pages
Global Urology Morcellators Market Growth 2026-2032
US$ 3,660.00
The global Urology Morcellators market size is predicted to grow from US$ 119 million in 2025 to US$ 161 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032. Urology morcellato...
January 2026
115 pages
Global Urology Video Endoscopes Market Growth 2026-2032
US$ 3,660.00
The global Urology Video Endoscopes market size is predicted to grow from US$ 288 million in 2025 to US$ 448 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032. Urology video...
January 2026
126 pages
Global Zero Helium Boil-off MRI Market Growth 2026-2032
US$ 3,660.00
The global Zero Helium Boil-off MRI market size is predicted to grow from US$ 4710 million in 2025 to US$ 7544 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032. The zero-hel...
January 2026
89 pages
Cell Therapy CDMO Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Other Service Types), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The cell therapy CDMO market size is expected to grow from US$ 4.12 billion in 2024 to US$ 21.92 billion by 2031; it is projected to register a CAGR of 27.1% during 2025-2031. The increasing prevalenc...
January 2026
217 pages
Injectable Drug Delivery Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type [Conventional Drug Delivery Devices and Advanced Drug Delivery Devices (Prefilled Syringes, Pen Injectors, Autoinjectors, Needle-Free Injectors, Wearable Injectors, and Other Advanced Types)], Formulation [Conventional Drug Delivery (Solutions, Reconstituted/ Lyophilized formulations, Suspensions, and Emulsions), Novel Drug Delivery (Colloidal Dispersion, Microparticles, Other Novel Drug Delivery), Long Acting Injectable Formulations], Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), Therapeutic Application (Diabetes, Oncology, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases, Pain Management, and Other Therapeutic Application), Usability (Disposable Injectors, Reusable Injectors), Route of Administration (Sub-cutaneous, Intramuscular, Intravenous, and Other Route of Administration), End User (Pharmaceutical and Biopharma Companies, CMOs, and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
According to our new research study on “Injectable Drug Delivery Market Forecast to 2031 –Global Analysis – by Type, and End User,” the market is anticipated to grow from US$ 40.56 billion in 2024 to...
January 2026
476 pages
